The apnea test is an essential component in the clinical determination of brain death, however it may incur a significant risk of complications such as hypotension, hypoxia and even cardiac arrest. We analyzed the risk factors associated with a failed apnea test during brain death assessment in order to predict and avoid these adverse events. Methods: Medical records on apnea tests performed for brain-dead donors at our institution between January 2009 and January 2016 were retrospectively reviewed. Age, gender, etiology of brain death, use of catecholamines and results of arterial blood gas analysis (ABGA), systolic/diastolic blood pressure (SBP/DBP), mean arterial pressure and central venous pressure prior to apnea test initiation were collected as variables. A-a gradient and P aO2 /F iO2 were calculated for more precise assessment of the respiratory system. In total, 267 cases were divided into two groups based on those who completed the apnea test and those who failed the test. Results: 13 cases failed the apnea test. Among them, seven cases failed due to severe hypotension (SBP < 60 mmHg) and the others failed due to refractory hypoxia. In terms of hemodynamic state, SBP was significantly higher in the completed test group than the failed group (126.5 ± 23.9 vs. 103 ± 15.2, respectively; p = 0.001). In ABGA, the completed test group showed significantly higher P aO2 / F iO2 (313.6 ± 229.8 vs. 141.5 ± 131.0, respectively; p = 0.008) and a lower A-a gradient (278.2 ± 209.5 vs. 506.2 ± 173.1, respectively; p = 0.000). In multivariable analysis, low SBP (p = 0.003) and high A-a gradient (p = 0.044) were independent risk factors associated with a failed apnea test. Conclusions: Although the unexpected adverse events during the apnea test for brain death determination do not occur frequently, they can be fatal. If a brain-dead patient has low SBP and a high A-a gradient, clinicians should pay more attention and prepare for potential complications prior to the apnea test.
Introduction
Brain death is defined as the irreversible loss of all brain functions in the presence of definite coma and absence of brainstem reflexes. Brain death usually has a specific, identifiable cause, excluding hypoxic brain injury resulting from drug or alcohol intoxication, hypothermia and cardiac arrest. [1, 2] Most transplants that use organs retrieved from brain dead patients can be the best treatment option for a wide range of patients with end stage organ failure, when their conditions may not be improved through other clinical practices. However, the persistent shortage of donor organs continues as the number of patients waiting for organ transplants far exceeds the number of donor organs available. To reduce this problem, it is important to provide cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Materials and Methods
This study was conducted at a tertiary hospital in Korea To analyze respiratory status and lung function, the P aO2 /F iO2 ratio was measured and alveolar-arterial gradient (A-a gradient) was calculated using the equation suggested in the Mellemgaard's study: [6] A-a gradient = P AO2 -P aO2 , P AO2 = (
where P AO2 is partial pressure of oxygen dissolved in the pulmonary alveoli; P atm is barometric pressure(760 mmHg); P H20 is partial pressure of water (47 mmHg) at temperature of 37°C; and P aCO2 is partial pressure of carbon dioxide in arterial blood. This study is a retrospective study involving collection and analysis of medical record information and received approval from the Institutional Review Board of Seoul St. Mary's Hospital.
All subjects were intubated through the endotracheal route and receiving mechanical ventilation (MV) support, and their blood pressure was constantly monitored via the catheter inserted into the radial artery. Subjects received fluid substances and medication through a central venous catheter. Before apnea testing, blood was collected from the radial artery to determine standard P aCO2 and the fraction of inspired oxygen (F iO2 ) on MV was increased to 1.0 to achieve the process of pre-oxygenation for 10 minutes.
After the pre-oxygenation period, MV was discontinued and apnea test was performed by pushing the endotracheal tube close to the carina and administering oxygen of 6 L. All subjects were observed for signs of spontaneous breathing or chest or abdominal movements for up to 10 minutes. During this observation period, arterial blood samples were collected through a catheter placed in the radial artery to perform ABGA. If signs of spontaneous breathing/chest or abdominal movements are absent and the P aCO2 is ≥ 60 mmHg, we concluded that the apnea test is passed. However, if breathing effort is observed with severe hypotension (systolic blood pressure less than 60 mmHg) despite administration of fluids and vasopressors, P aCO2 of less than 60 mmHg, SpO2 (less than 85% ) for more than 1 minute, we aborted the apnea test and concluded that the apnea is failed.
SPSS software version 21.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. The p value of less than 0.05 was considered statistically significant.
Fisher's exact test was performed for categorical variables, and data were expressed as frequency and percentages. For continuous variables, student's t-test was performed, and data were expressed as mean ± standard deviation. Risk factors associated with apnea test failure were identified on multivariate logistic regression analysis after multicollinearity was ignored in linear regression method. The 95% confidence interval was used to estimate the odds ratio.
Results
The mean age of 267 potential brain dead donors was 46.9 years (range 18-69 years). One hundred and sixty six patients (62.2%) were male and 101 patients (37.8%) were female. In 254 (95.1%) of 267 subjects, an apnea test could be completed. However, in 13 patients (4.9%), an apnea test had to be aborted or failed due to progressive conditions and death, making a clinical determination of brain death impossible. Clinical characteristics of 13 subjects with aborted apnea tests are presented in Table 1 . The apnea test had to be aborted in 6 of them due to progressive hypotension and subsequent hemodynamic instability and in the remaining 7 patients due to severe refractory hypoxemia occurred after sustained SpO2 of less than 85%.
In Table 2 , the success and failure groups were compared with respect to clinical characteristics, and pre-apnea hemodynamics and ABGA results. There was no significant difference in mean age, gender and cause of brain death between the two groups, and the leading cause of brain death was subarachnoid hemorrhage in both groups To identify risk factors for apnea test failed or aborted, multivariate analysis was performed on the variables found to be significantly different in the two groups. To reduce the correlation between variables, the collinearity among the variables used in the linear regression was assessed, and pre-apnea systolic blood pressure, pH and P O2 (based on results of standard ABGA) and a-a gradient were finally used in the multiple regression analysis.
the P aO2 /F iO2 ratio was not included. As presented in Table   3 , arterial pH levels and P O2 were found to be not significant. However, low systolic blood pressure (Odds ratio likely to provide useful information on risk factors for respiratory system. In addition to brain death, patients with serious brain injury commonly develop acute lung injury as a result of neurological pulmonary edema and secondary inflammatory response. [9] In such a setting, the degree of acute lung injury can be assessed by the P aO2 / an apnea test and organ hypoperfusion, although maintenance of end-organ perfusion is critical for the preservation of organs to be donated. In this study, pre-apnea low systolic blood pressure was also found to be a significant risk factor associated with apnea test failure in multivariate analysis. To prevent apnea test failure induced by low systolic blood pressure, the administration of intravenous fluids, vasoconstrictors such as vasopressins and vasopressors such as catecholamine and dopamine is recommended. While vital signs are monitored closely, these medications can be administered in a timely manner. [14] In Korea, this study is the first to identify risk factors for apnea test failure. The findings of this study along with analysis strategies used, provide meaningful insights.
However this study has limitations. We could not determine cut-off value of each risk factor required to compile guidelines for pre-apnea treatment because it was not possible to identify effective cut off values with small sample size. To overcome this limitation, further large scale studies are needed to determine cut-off value of each risk factor for apnea test failure and prepare detailed guidelines for pre-apnea treatment.
In conclusion, we identified pre-apnea low systolic blood pressure and elevated a-a gradient (based on ABGA results) as independent risk factors for apnea test failure in potential brain dead donors. Given growing imbalance between supply and demand for organs for transplants, it is important than ever to modify these risk factors aggressively in an effort to reduce failure rates of apnea test and improve organ procurement.
